4-(diethylamino)benzaldehyde and Triple Negative Breast Neoplasms

4-(diethylamino)benzaldehyde has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hara, Y; Koyanagi, S; Matsunaga, N; Ogino, T; Ohdo, S; Tanaka, T	1

Other Studies

1 other study(ies) available for 4-(diethylamino)benzaldehyde and Triple Negative Breast Neoplasms

Article	Year
Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor. Cancer research, 2018, 07-01, Volume: 78, Issue:13 Topics: Aldehyde Dehydrogenase; Animals; Benzaldehydes; Cell Line, Tumor; Circadian Clocks; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Nerve Tissue Proteins; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Microenvironment; Wnt Proteins	2018

Article

Year

Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor.

Cancer research, 2018, 07-01, Volume: 78, Issue:13

Topics: Aldehyde Dehydrogenase; Animals; Benzaldehydes; Cell Line, Tumor; Circadian Clocks; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Nerve Tissue Proteins; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Microenvironment; Wnt Proteins

2018